This Week in Nature

In Nature this week, research led by Novartis' Feng Cong identified a new molecule in the Wnt signaling pathway that could potentially be a target in Wnt-dependent cancers. Using a chemical genetic screen, the scientists found that XAV939, a small molecule that selectively inhibits beta-catenin-mediated transcription, effectively stabilizes axin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.